The European Map of Axial Spondyloarthritis: Capturing the Patient Perspective-an Analysis of 2846 Patients Across 13 Countries

Curr Rheumatol Rep. 2019 Mar 12;21(5):19. doi: 10.1007/s11926-019-0819-8.

Abstract

Purpose of review: Scientific research in axial spondyloarthritis (axSpA) has grown significantly. Nevertheless, the patient perspective remains insufficiently explored. Using a cross-sectional survey, the European Map of Axial Spondyloarthritis (EMAS) describes how patients living with self-reported axSpA experience their disease physically, psychologically, and socially.

Recent findings: 2846 patients participated: mean age 43.9 ± 12.3 years, 61.3% female, mean disease duration was 17.2 ± 12.4 years, and 71.3% were HLA-B27 positive. Mean diagnostic delay was 7.4 ± 8.4 years. Mean BASDAI score was 5.5 ± 2.0 and 75.7% reported moderate/severe spinal stiffness throughout the day. Daily life was substantially impaired: 74.1% reported difficulties finding a job due to the disease, and 61.5% reported psychological distress. EMAS results showed long diagnostic delay and substantial physical and psychological burden, indicating important unmet needs for patients. Furthermore, axSpA restricted patients' ability to participate in their daily routine and lead a productive work life. Understanding the patient's perspective can improve both health outcomes and shared decision-making between patient and rheumatologist.

Keywords: Ankylosing spondylitis; Axial spondyloarthritis; Burden of the disease; Europe; Non-radiographic axial spondyloarthritis; Patient’s perspective; Shared decision-making.

Publication types

  • Review

MeSH terms

  • Adult
  • Cost of Illness*
  • Delayed Diagnosis
  • Female
  • Humans
  • Male
  • Middle Aged
  • Quality of Life / psychology*
  • Severity of Illness Index
  • Spondylarthritis / diagnosis*
  • Spondylarthritis / psychology